Ct-p44 Upd Today

| Parameter | Specification | | :--- | :--- | | | CT-P44 | | Input Voltage | 100-240 VAC, 50/60 Hz | | Output Voltage | 48 VDC (Adjustable 42-58V) | | Max Current | 90A | | Efficiency | ≥ 94% | | Cooling Method | Forced Air (Smart Fan) | | Dimensions | 450mm x 220mm x 150mm | | Weight | 7.2 kg (15.8 lbs) | | Operating Temp | -20°C to +50°C |

CT-P44 is a bispecific antibody designed to simultaneously target two immune checkpoints, PD-1 and LAG-3, which are often co-expressed on T cells. By blocking both pathways, CT-P44 aims to enhance anti-tumor immune responses and overcome the limitations of single-agent checkpoint inhibitors. The antibody is currently being developed by Celltrion, a South Korean biopharmaceutical company, and has shown promising results in preclinical studies.

It seems you're referencing in the context of a scientific paper , likely a clinical study or pharmacological research.

Note: If "ct-p44" refers to a specific document code, legal form, or a different niche product, please provide context for a more targeted revision.